
Ergéa UK has opened a new specialist clinic in Alderley Edge, offering low-dose radiotherapy treatment (LDRT) for people with conditions including osteoarthritis, tennis elbow and plantar fasciitis, a common cause of heel pain.
The opening introduces a new area of activity for Ergéa UK, alongside its established Managed Equipment Services business serving NHS and private hospitals.
The Ergéa Alderley Edge Low-Dose Radiotherapy Clinic, located at Alderley Edge Medical Centre, provides consultant-led assessment and treatment for a range of specific conditions that can cause pain, discomfort and difficulties with everyday activities.
One of the most common conditions assessed and treated at the clinic is osteoarthritis, which affects millions of people across the UK. It can cause joint pain and stiffness, making everyday activities such as walking, climbing stairs or getting up from a chair more difficult.
The clinic also treats a range of other conditions, including painful tendon problems, such as those affecting the Achilles tendon at the back of the heel; bursitis, which causes pain and inflammation around joints; Dupuytren’s disease, which can cause the fingers to bend towards the palm; Ledderhose disease, which causes lumps to develop in the soles of the feet; and keloid scarring, where raised scars grow beyond the boundaries of the original wound.
The opening gives people in Cheshire and across the North West access to a local specialist clinic where they can be assessed to determine whether low-dose radiotherapy is an appropriate treatment option for their diagnosed condition.
Radiotherapy is best known for its role in cancer treatment. LDRT, however, uses much lower doses of radiation than those typically used to treat cancer. For certain diagnosed conditions, it may help reduce inflammation and relieve pain, making it easier to move more comfortably. For other conditions, treatment may help slow disease progression.
Before treatment is considered, each patient has an individual clinical assessment reviewing their symptoms, previous treatments and whether LDRT is appropriate for their condition.
The clinic combines UK clinical expertise with experience drawn from Ergéa’s wider network. Ergéa is a pan-European specialist healthcare company operating through hospital partnerships and proprietary medical centres. At its radiotherapy centres in Germany, Ergéa treats more than 20,000 patients each year with low-dose radiotherapy.
The clinic’s Chief Medical Officer, Dr Richard Shaffer, is a consultant radiation oncologist with extensive experience in low-dose radiotherapy. Dr Shaffer has treated more than 3,000 patients using LDRT, co-authored the Royal College of Radiologists’ radiotherapy guidelines and trains and mentors other doctors in the field.
Dr. Richard Shaffer said: “Persistent pain can affect a person’s ability to move, disrupt sleep, limit everyday activities and prevent people from doing the things they enjoy. For suitable patients with conditions such as osteoarthritis or plantar fasciitis, low-dose radiotherapy may help reduce pain when physiotherapy, pain medication and other treatments have not provided sufficient relief. At our new clinic in Alderley Edge, we assess each patient carefully, explain the potential benefits and risks, and help them understand whether low-dose radiotherapy is right for them. Our aim is to help people move more comfortably and enjoy a better quality of life.”
The clinic is led by Chief Executive Officer Abe Elkinson, who has more than 20 years of experience developing and delivering patient-centred healthcare services in partnership with the NHS and other healthcare organisations.
Abe Elkinson said: “Our mission is to provide exceptional radiotherapy services that improve patient well-being by helping relieve pain and disability, potentially reducing the need for surgery and long-term medication. We deliver this through a highly experienced clinical team, advanced, purpose-built radiotherapy technology and a compassionate, responsive approach to patient care. This allows us to provide professional, personalised care, ensuring every patient feels supported throughout their treatment journey.”











































